BenzingaMon, 11 May 2026 15:44:53 GMTFDA Aligns With MoonLake On Lead Drug Submission Plans, Stock SoarsMLTX-1.52%
Investors Business DailyMon, 11 May 2026 15:08:40 GMTMoonLake Clears A Key Regulatory Hurdle, And Shares RocketMLTX-1.52%
The Motley FoolSat, 18 Apr 2026 14:17:01 GMTThe CEO of MoonLake Immunotherapeutics Dumped Shares Worth $2.8 Million. Should Investors Avoid the Stock?MLTX-1.52%
The Motley FoolTue, 07 Apr 2026 18:07:33 GMTBiotech Fund BVF Trims MoonLake Stake, Sells $63M in SharesMLTX-1.52%
Seeking AlphaTue, 24 Feb 2026 18:50:12 GMTMoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On GoalMLTX-1.52%